University of Rochester Medical Center
Rochester, New York, 14642, United States
NCT Number: NCT05571189
The purpose of this study is to evaluate whether a home rehabilitation program after hospitalization for acute pulmonary embolism (PE) improves clinical outcomes at 3 months compared to usual care. Daily physical activity tasks that incorporate heart rate monitoring will be sent through email or text. This information could help improve the management of acute PE.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Rochester, New York, 14642, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will receive a text each day with instructions about the daily activity they should complete for that day.
Participants will receive a text each day with no instructions about daily activity. It will have messages like "have a nice day."
Time frame: 10 weeks
The Actigraph triaxial accelerometer will be used to monitor continuous activity at home on the non-dominant wrist. The accelerometer data will be downloaded and will include the vector magnitude count.
Time frame: 10 weeks
The Actigraph triaxial accelerometer will be used to monitor continuous activity at home on the non-dominant wrist. The accelerometer data will be downloaded and will include the mean amplitude deviation.
Time frame: 12 weeks
Participants will be evaluated by a physician to determine if they have post PE-syndrome
Time frame: 12 weeks
The Actigraph triaxial accelerometer will be used to monitor the number of steps taken at home on the non-dominant wrist. The accelerometer data will be downloaded and will include the step count.
Time frame: 12 weeks
The Actigraph triaxial accelerometer will be used to monitor the amount of activity taken at home on the non-dominant wrist. The accelerometer data will be downloaded and will include the amount of activity.
Time frame: 12 weeks
The PROMIS questionnaire ranges from 0-99 with higher scores indicating worse outcome.
Time frame: 12 weeks
The Emphasis 10 questionnaire ranges from 0-50 with higher scores indicating worse quality of life.
Time frame: 12 weeks
The pulmonary embolism quality of life questionnaire ranges from 1 to 27 with higher scores indicating worse outcomes.
Time frame: 12 weeks
Time frame: 12 weeks
Time frame: 12 weeks
Oxygen use will be measured by a measured by portable K5 metabolic analyzer.
Time frame: 12 weeks
Carbon Dioxide use will be measured by a measured by portable K5 metabolic analyzer.
Time frame: 12 weeks
University of Rochester
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06015529
Cardiovascular Diseases, Embolism
Brussels, Belgium
View Trial DetailsNCT04014972
Acute Aortic Syndrome, Aneurysm
View Trial DetailsNCT07689136
Cardiovascular Diseases, Deep Vein Thrombosis
Tunis, Tunisia
View Trial DetailsNCT06183944
Cardiovascular Diseases, Embolism
Toulon, France
View Trial Details